Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy

24 Oct 2015

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Genetic factors in colorectal cancer
Share to RNA modifications and cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 26453961
DOI: 10.1016/j.ygeno.2015.10.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapyPMID 26453961Read ↗

Methylation-Based Therapies for Colorectal CancerSemantic proximity Read ↗

A novel epigenetic signature to predict recurrence-free survival in patients with colon cancerSemantic proximity Read ↗

Cross talk between acetylation and methylation regulators reveals histone modifier expression patterns posing prognostic and therapeutic implications on patients with colon cancerSemantic proximity Read ↗

Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer PatientsSemantic proximity Read ↗

ETV5 expression positively correlates with promoter methylation and predicts response for 5-FU-based adjuvant therapy response in proximal colon cancerSemantic proximity Read ↗

DNA demethylation and tri-methylation of H3K4 at the TACSTD2 promoter are complementary players for TROP2 regulation in colorectal cancer cellsSemantic proximity Read ↗

TET2–BCLAF1 transcription repression complex epigenetically regulates the expression of colorectal cancer gene Ascl2 via methylation of its promoterSemantic proximity Read ↗

Intracellular hyaluronic acid-binding protein 4 (HABP4): a candidate tumor suppressor in colorectal cancerSemantic proximity Read ↗

Detection and clinical significance of CEACAM5 methylation in colorectal cancer patientsSemantic proximity Read ↗

Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancerSemantic proximity Read ↗

Impact of Global DNA Methylation in Treatment Outcome of Colorectal Cancer PatientsSemantic proximity Read ↗

Human Endogenous Retroviruses Long Terminal Repeat Methylation, Transcription, and Protein Expression in Human Colon CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.